Voloridge Investment Management, LLC Coherus Bio Sciences, Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.95 - $15.41 $3.43 Million - $4.08 Million	-264,882 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$14.42 - $21.39 $896,332 - $1.33 Million	62,159 Added 30.66%	264,882 $3.87 Million
Q4 2020 Feb 16, 2021	BUY	$16.56 - $18.94 $3.36 Million - $3.84 Million	202,723 New	202,723 $3.52 Million
Q4 2019 Feb 14, 2020	SELL	$16.33 - $21.37 $884,612 - $1.16 Million	-54,171 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.3 - $23.37 $882,987 - $1.27 Million	54,171 New	54,171 $1.1 Million

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.